[Translation] A randomized, open-label, controlled, multicenter phase III clinical study comparing MW2821 with investigator's choice of chemotherapy for the treatment of unresectable locally advanced or metastatic urothelial carcinoma who have previously received platinum-containing chemotherapy and PD-(L)1 inhibitors
比较9MW2821和研究者选择的化疗在既往接受过含铂化疗和PD-(L)1抑制剂治疗局部晚期或转移性尿路上皮癌患者中的无进展生存期和总生存期
[Translation] Comparison of progression-free survival and overall survival between 9MW2821 and investigator's choice of chemotherapy in patients with locally advanced or metastatic urothelial carcinoma who have received prior treatment with platinum-containing chemotherapy and a PD-(L)1 inhibitor